Lee Garner, MD
Obstetrics & Gynecology · Wilmington, NCNPI 1699092346
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $358 of the $448 with a category attached, or 79.9%. 9 manufacturers reported payments, led by Novo Nordisk at 27.5% of the total. That places this record below the midpoint for obstetrics & gynecology clinicians in NC, where the typical reported total is $453.
Across 12 payments — averaging $37.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$123
- Astellas Pharma US Inc$108
- Pfizer$51
- Sumitomo Pharma America, Inc.$39
- Smith+Nephew$33
- AMAG Pharmaceuticals, Inc.$31
- plus $62 from 3 others
What the payments were for
- Food & beverage$35880%
- Education$9020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 1 | $123 |
| Astellas Pharma US Inc | 2 | $108 |
| Pfizer | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Smith+Nephew | 1 | $33 |
| AMAG Pharmaceuticals, Inc. | 1 | $31 |
| Mayne Pharma Commercial LLC | 1 | $29 |
| Bayer | 1 | $17 |
| Shield Therapeutics Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$123
How this compares
$448 in reported general payments places this provider in the 45th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 162 | $13,158 |
| YuvafemEstradiol | 26 | $3,296 |
| Estradiol (Twice Weekly)Estradiol | 29 | $2,310 |
| Estradiol (Once Weekly)Estradiol | 18 | $1,947 |
| Clobetasol Propionate | 34 | $1,073 |
| ProgesteroneProgesterone, Micronized | 22 | $1,055 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $487 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Wilmington
- Laura McKainWilmington$475K
- Sandra HallWilmington$21K
- Jerry MatkinsCharlotte$481K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Jack IngeRaleigh$157K
- Geeta SwamyDurham$142K
- Karie LafleurAsheville$135K
- Ty RobinsonHigh Point$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.